Loading

XORTX Therapeutics Inc.

June 04, 2024
Company Presentation
Other
Company Presentation Theater 1
XORTX Therapeutics, a late-stage clinical pharmaceutical company dedicated to developing innovative therapies to improve the quality of life of patients with progressive kidney disease. Our programs are designed to manage aberrant purine metabolism and reduce high uric acid and slow progression of kidney disease.
XORTX Therapeutics Inc.
Company Website: http://XORTX.com
Lead Product in Development: XRx-008 program for ADPKD
Number Of Unlicensed Products (For Which You Are Seeking Partners): XRx-008 program for ADPKD

Exchange

Nasdaq Toronto Venture Exchange

Ticker

XRTX - Nasdaq XRTX - TSXV

Company HQ City

Calgary

Company HQ State

Alberta

Company HQ Country

Canada

CEO/Top Company Official

Allen Davidoff

Development Phase of Primary Product

Phase III
Speakers
Allen Davidoff
CEO, President, Director
XORTX Therapeutics Inc.
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS